Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

26
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
26
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

30
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
30
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

32
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
32
Urinary Tract Calculi VI: Surgical Management01:25

Urinary Tract Calculi VI: Surgical Management

26
Procedures for Kidney StonesMedical intervention is necessary when kidney stones or renal calculi are too large to pass spontaneously (typically greater than 5 millimeters) when stones are accompanied by symptomatic infection (such as fever or pyelonephritis), when they impair kidney function, or when they cause persistent symptoms like severe pain, nausea, or urinary retention. Additionally, patients with only one kidney or those who cannot be treated with medical management also require...
26
Methods Of Healthcare Delivery System01:26

Methods Of Healthcare Delivery System

3.5K
At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
3.5K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

33
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Cardiovascular Outcomes After Percutaneous Coronary Intervention in Patients With Serious Mental Illness.

International journal of psychiatry in medicine·2026
Same author

Frailty as a predictor of adverse in-hospital outcomes in older patients with Takotsubo cardiomyopathy.

Journal of geriatric cardiology : JGC·2026
Same author

SGLT2 Inhibitors and Progression of Chronic Kidney Disease in Patients with Elevated Lipoprotein(a): A Real-World Cohort Study.

Journal of cardiovascular pharmacology·2026
Same author

Impact of comorbid mental disorders on in‑hospital mortality and complications after ST‑segment elevation myocardial infarction.

Future cardiology·2026
Same author

Unexpected Intraoperative Diagnosis of Acute Type A Aortic Dissection in an Octogenarian: Tailored Repair.

JACC. Case reports·2026
Same author

Comparative cardiovascular toxicity of immune checkpoint inhibitors: A real-world cohort study.

The American journal of the medical sciences·2026

関連する実験動画

Updated: Sep 9, 2025

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
13:07

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression

Published on: January 15, 2022

4.0K

米国における血管内冠動脈リトトリプシーの実施:健康の社会的決定因子

Abdul Rasheed Bahar1, Yasemin Bahar1, Ali Rabib2

  • 1Department of Internal Medicine, Wayne State University, Detroit, Michigan, USA.

JACC. Advances
|September 2, 2025
PubMed
まとめ
この要約は機械生成です。

冠動脈リトトリプシーの使用は患者の人口統計によって異なりますが,女性,アフリカ系アメリカ人,低所得者はこの治療を受ける可能性が低いです. これらの格差は,先進的な心臓血管介入への 平等なアクセスが必要であることを強調しています.

キーワード:
NIS について冠動脈疾患格差についてリトトリプシー

さらに関連する動画

Novel Percutaneous Approach for Deployment of 3D Printed Coronary Stenosis Implants in Swine Models of Ischemic Heart Disease
06:39

Novel Percutaneous Approach for Deployment of 3D Printed Coronary Stenosis Implants in Swine Models of Ischemic Heart Disease

Published on: February 18, 2020

6.9K
Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

523

関連する実験動画

Last Updated: Sep 9, 2025

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
13:07

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression

Published on: January 15, 2022

4.0K
Novel Percutaneous Approach for Deployment of 3D Printed Coronary Stenosis Implants in Swine Models of Ischemic Heart Disease
06:39

Novel Percutaneous Approach for Deployment of 3D Printed Coronary Stenosis Implants in Swine Models of Ischemic Heart Disease

Published on: February 18, 2020

6.9K
Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

523

科学分野:

  • 心血管医学
  • 医療サービス研究
  • 医療 介入

背景:

  • 医療へのアクセスの格差は 心血管疾患の介入において依然として残っています
  • 冠動脈リトトリプシーは,結晶化した冠動脈の病変のための新しい治療法であり,社会統計学的要因に基づいて変動する利用率を示しています.

研究 の 目的:

  • 米国における冠動脈リトトリプシーの利用における 性別,人種,収入,病院の特徴の影響を調べる.
  • この先進的な心臓血管治療へのアクセスにおける 社会統計学的格差を特定するためです

主な方法:

  • 2021年全国の入院患者サンプルデータベースの分析.
  • ICD-10コードを使用して,皮膚経冠動脈介入 (PCI) とリトトリプシーを受けている患者の識別.
  • 多変数ロジスティック回帰と傾向スコアのマッチングは,リトトリプシーの使用に対する社会統計学的要因,併発症,病院特性の影響を評価する.

主要な成果:

  • 261,260人のPCI患者のうち,0. 38%がリトトリプシーを受けた.
  • 女性,アフリカ系アメリカ人,メディケイドの患者は,男性,白人患者,メディケアの受給者と比較して,リトトリプシーを受ける確率が有意に低かった.
  • 高所得四分位および南部の地域は,リトトリプシーの利用率の増加と関連していました.

結論:

  • 性別,人種,保険状況,所得,地域によって冠動脈リトトリプシーの利用の格差が大きい.
  • これらの発見は,先進的な心臓血管治療への公平なアクセスを確保するために,標的を絞った介入の必要性を強調しています.
  • 病気の流行の潜在的な違いを超えて,治療の割り当てにおける持続的な不平等に対処するために,さらなる調査が必要である.